Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02558348
Title Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Advenchen Laboratories, LLC
Indications

fallopian tube cancer

peritoneum cancer

endometrial carcinoma

ovarian cancer

cervical squamous cell carcinoma

Therapies

Anlotinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST